View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Eribulin 1.23 / Margetuximab 15, Breast Cancer
Protocol-ID: 1872 V1.1 (Mini), ERIB1.23/MARG15, Breast CaIndication(s)
- Breast Cancer (HER2+); ICD-10 C50.-
Links
- Prescribing information for Margetuximab (MARGENZA) FDA [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 18.08.2024